Condylomata Acuminata - Prevention & control
Research News and Information

Sunday, November 22, 2009

Human papillomavirus knowledge and awareness among undergraduates in healthcare training in New Zealand.

7 Oct 2009 AIMS: To describe knowledge of HPV and its transmission, knowledge of the HPV vaccine, and awareness of free HPV vaccine for 12-18 year old New Zealand females; and to assess whether there are significant age and gender differences in HPV-related ... Read more...

Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge.

30 Jul 2009 STUDY OBJECTIVE: Human papillomavirus (HPV), the most common sexually transmitted infection in the United States, can be contracted by young girls shortly after sexual debut. Human papillomavirus can lead to cervical and anogenital cancers and ... Read more...

Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.

30 Jul 2009 BACKGROUND: Data on the burden of genital warts in terms of treatment costs and detriment to quality of life (QoL) are required to assess cost-effectiveness of quadrivalent human papillomavirus vaccination. We investigated the cost of treatment and ... Read more...

Latest indexed articles for 'Condylomata Acuminata - Prevention & control'

These are the very latest articles for this heading:

• Human papillomavirus knowledge and awareness among undergraduates in healthcare training in New Zealand. 7 Oct 2009
• HPV vaccine strategies: the cost of HPV and the choice of vaccine. 30 Aug 2009
• Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. 30 Jul 2009
• Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom. 30 Jul 2009
• Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. 30 May 2009
• [Expected impact of a quadrivalent HPV vaccine in France] 26 May 2009
• The HPV vaccines--which to prefer? 29 Apr 2009
• Human papillomavirus vaccines. WHO position paper. 8 Apr 2009
• [Value of general human papillomavirus vaccination in sexually active women] 5 Apr 2009
• Human papillomavirus, genital warts, and vaccines. 30 Mar 2009
• [Knowledge of HPV-related genital lesions and of anti-HPV vaccination in a sample of women of north-eastern Italy] 30 Mar 2009
• [Knowledge of human papilloma virus-associated disease among women in general practice] 28 Mar 2009
• Potential barriers to HPV immunization: from public health to personal choice. 30 Dec 2008
• The quadrivalent human papillomavirus vaccine. 29 Nov 2008
• [Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project] 29 Nov 2008
• (Not) warts and all. All data on both vaccines must be considered. 17 Nov 2008
• (Not) warts and all. "Annoyance" of genital warts. 17 Nov 2008
• (Not) warts and all. Government fully considered HPV vaccine. 17 Nov 2008
• [Quality of life of patients with condyloma] 15 Nov 2008
• Human papillomavirus vaccines and vaccine implementation. 30 Oct 2008

See a longer list of these articles.

Technical information about 'Condylomata Acuminata'

Definition: Sexually transmitted form of anogenital warty growth caused by the human papillomaviruses.

Descriptor UI: D003218

Alternative terms: Condylomata Acuminata; Venereal Warts; Venereal Wart; Wart, Venereal; Warts, Venereal; Genital Warts; Genital Wart; Wart, Genital; Warts, Genital;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C02.256.650.810.217; C02.800.801.220; C02.825.810.110; C02.928.914.217; C17.800.838.790.810.110;

History Note: 72(64)

Technical Notes: coordinate IM with precoordinated organ/disease term (IM) + specific virus (IM) if pertinent